Burton G Malkiel - Net Worth and Insider Trading
Burton G Malkiel Net Worth
The estimated net worth of Burton G Malkiel is at least $589,125 dollars as of 2024-09-20. Burton G Malkiel is the Director of Theravance Biopharma Inc and owns about 71,757 shares of Theravance Biopharma Inc (TBPH) stock worth over $589,125. Details can be seen in Burton G Malkiel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Burton G Malkiel has not made any transactions after 2018-05-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Burton G Malkiel
Burton G Malkiel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Burton G Malkiel owns 3 companies in total, including Theravance Biopharma Inc (TBPH) , Innoviva Inc (INVA) , and BKF Capital Group Inc (BKFG) .
Click here to see the complete history of Burton G Malkiel’s form 4 insider trades.
Insider Ownership Summary of Burton G Malkiel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TBPH | Theravance Biopharma Inc | 2018-05-21 | director |
| INVA | Innoviva Inc | 2007-07-03 | director |
| BKFG | BKF Capital Group Inc | 2005-03-23 | director |
Burton G Malkiel Latest Holdings Summary
Burton G Malkiel currently owns a total of 1 stock. Burton G Malkiel owns 71,757 shares of Theravance Biopharma Inc (TBPH) as of May 21, 2018, with a value of $589,125.
Latest Holdings of Burton G Malkiel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TBPH | Theravance Biopharma Inc | 2018-05-21 | 71,757 | 8.21 | 589,125 |
Holding Weightings of Burton G Malkiel
Burton G Malkiel Form 4 Trading Tracker
According to the SEC Form 4 filings, Burton G Malkiel has made a total of 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. The most-recent trade in Theravance Biopharma Inc is the acquisition of 1,000 shares on May 21, 2018, which cost Burton G Malkiel around $22,540.
Insider Trading History of Burton G Malkiel
- 1
Burton G Malkiel Trading Performance
GuruFocus tracks the stock performance after each of Burton G Malkiel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Burton G Malkiel is 25.49%. GuruFocus also compares Burton G Malkiel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Burton G Malkiel within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Burton G Malkiel's insider trading performs compared to the benchmark.
Performance of Burton G Malkiel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.67 | | | | | |
| Relative Return to S&P 500(%) | 16.04 | | | | | |
Burton G Malkiel Ownership Network
Burton G Malkiel Owned Company Details
What does Theravance Biopharma Inc do?
Who are the key executives at Theravance Biopharma Inc?
Burton G Malkiel is the director of Theravance Biopharma Inc. Other key executives at Theravance Biopharma Inc include 10 percent owner Eli Samaha , SVP & Comm & Medical Affairs Rhonda Farnum , and SVP & Development Richard A Graham .
Theravance Biopharma Inc (TBPH) Insider Trades Summary
Over the past 18 months, Burton G Malkiel made no insider transaction in Theravance Biopharma Inc (TBPH). Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include a net sale of 19,057 shares made by Richard A Graham , a net sale of 10,229 shares made by Rhonda Farnum , and a net purchase of 2,498,924 shares made by Eli Samaha .
In summary, during the past 3 months, insiders sold 4,000 shares of Theravance Biopharma Inc (TBPH) in total and bought 999,800 shares, with a net purchase of 995,800 shares. During the past 18 months, 29,286 shares of Theravance Biopharma Inc (TBPH) were sold and 2,498,924 shares were bought by its insiders, resulting in a net purchase of 2,469,638 shares.
Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Theravance Biopharma Inc Insider Transactions
Burton G Malkiel Mailing Address
Above is the net worth, insider trading, and ownership report for Burton G Malkiel. You might contact Burton G Malkiel via mailing address: C/o Prudential Financial Inc, 751 Broad St. 4th Fl., Newark Nj 07102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
